Product Monograph - Chloramphenicol (Pharma Stulln)
ADVERSE REACTIONS
Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.
OVERDOSAGE
For management of a suspected drug overdose, contact your regional Poison Control Centre.
DOSAGE AND ADMINISTRATION
Apply a small amount (1 cm strip) to the lower conjunctiva sac(s) at bedtime as a supplement to the drops.
AVAILABILITY
Each gram of sterile ophthalmic ointment contains: Chloramphenicol USP 1% (10 mg/g); and the following non-medicinal ingredients: mineral oil, polysorbate 60 and white petrolatum. Available in 3.5 grams tubes.
STORAGE CONDITIONS
Store between 15°C and 30°C. Keep container tightly closed.
PHARMACEUTICAL INFORMATION
Structural Formula:

Chemical Name: 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4- nitrophenyl)ethyl]-, [R- (R*,R*)]-acetamide
Molecular Formula: C11H12Cl2N2O5
Molecular Weight: 323.13
Description: Fine, white to grayish-white or yellowish-white, needle-like crystals or elongated plates. Freely soluble in alcohol, in propylene glycol, in acetone, and in ethyl acetate; slightly soluble in water.
